Onconetix, Inc. (ONCO) stock
ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.00+0.09 (+3.09%)
Close on Nov 17, 2026Market cap $11.85MP/E –Yield –
Onconetix cash
Cash and short-term investments held at the end of each period.
Onconetix's cash was $5.94M at Jun 30, 2026. For fiscal 2025 it was $5.22M, up 707.5% from the year before. The highest annual figure on record is $25.75M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.22M | +707.5% |
| FY2024 | Dec 31, 2024 | $646.50K | -85.8% |
| FY2023 | Dec 31, 2023 | $4.55M | -82.3% |
| FY2022 | Dec 31, 2022 | $25.75M | +1235.4% |
| FY2021 | Dec 31, 2021 | $1.93M | -55.2% |
| FY2020 | Dec 31, 2020 | $4.31M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.94M | +1995.9% |
| Q1 FY2026 | Mar 31, 2026 | $3.72M | +135.6% |
| Q4 FY2025 | Dec 31, 2025 | $5.22M | +707.5% |
| Q3 FY2025 | Sep 30, 2025 | $836.56K | +145.0% |
| Q2 FY2025 | Jun 30, 2025 | $283.52K | -69.5% |
| Q1 FY2025 | Mar 31, 2025 | $1.58M | -64.7% |
| Q4 FY2024 | Dec 31, 2024 | $646.50K | -85.8% |
| Q3 FY2024 | Sep 30, 2024 | $341.50K | -95.5% |
| Q2 FY2024 | Jun 30, 2024 | $930.54K | -89.9% |
| Q1 FY2024 | Mar 31, 2024 | $4.46M | -82.7% |
| Q4 FY2023 | Dec 31, 2023 | $4.55M | -84.4% |
| Q3 FY2023 | Sep 30, 2023 | $7.65M | -65.6% |
| Q2 FY2023 | Jun 30, 2023 | $9.22M | -50.4% |
| Q4 FY2022 | Dec 31, 2022 | $25.75M | +1235.4% |
| Q3 FY2022 | Sep 30, 2022 | $29.14M | +962.6% |
| Q2 FY2022 | Jun 30, 2022 | $22.24M | +506.1% |
| Q1 FY2022 | Mar 31, 2022 | $18.61M | +359.2% |
| Q4 FY2021 | Dec 31, 2021 | $1.93M | -55.2% |
| Q3 FY2021 | Sep 30, 2021 | $2.74M | – |
| Q2 FY2021 | Jun 30, 2021 | $3.67M | – |
| Q1 FY2021 | Mar 31, 2021 | $4.05M | – |
| Q4 FY2020 | Dec 31, 2020 | $4.31M | – |
See a number that looks wrong?